DE69739317D1 - Früher nachweis einer lysosomalen speicher-krankheit - Google Patents

Früher nachweis einer lysosomalen speicher-krankheit

Info

Publication number
DE69739317D1
DE69739317D1 DE69739317T DE69739317T DE69739317D1 DE 69739317 D1 DE69739317 D1 DE 69739317D1 DE 69739317 T DE69739317 T DE 69739317T DE 69739317 T DE69739317 T DE 69739317T DE 69739317 D1 DE69739317 D1 DE 69739317D1
Authority
DE
Germany
Prior art keywords
lysosomal storage
storage disease
previous identification
detection
lamp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69739317T
Other languages
German (de)
English (en)
Inventor
Peter J Meikle
Douglas A Brooks
John J Hopwood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Womens and Childrens Hospital Adelaide
Original Assignee
Womens and Childrens Hospital Adelaide
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Womens and Childrens Hospital Adelaide filed Critical Womens and Childrens Hospital Adelaide
Application granted granted Critical
Publication of DE69739317D1 publication Critical patent/DE69739317D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DE69739317T 1996-05-17 1997-05-16 Früher nachweis einer lysosomalen speicher-krankheit Expired - Lifetime DE69739317D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN9917A AUPN991796A0 (en) 1996-05-17 1996-05-17 Early detection of lysosomal storage disorders
PCT/AU1997/000304 WO1997044668A1 (en) 1996-05-17 1997-05-16 Early detection of lysosomal storage disorders

Publications (1)

Publication Number Publication Date
DE69739317D1 true DE69739317D1 (de) 2009-04-30

Family

ID=3794228

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69739317T Expired - Lifetime DE69739317D1 (de) 1996-05-17 1997-05-16 Früher nachweis einer lysosomalen speicher-krankheit

Country Status (10)

Country Link
US (2) US6759189B1 (enExample)
EP (1) EP1021725B1 (enExample)
JP (3) JP3837711B2 (enExample)
AT (1) ATE426169T1 (enExample)
AU (1) AUPN991796A0 (enExample)
CA (2) CA2253875C (enExample)
DE (1) DE69739317D1 (enExample)
IL (1) IL127033A (enExample)
NZ (1) NZ332641A (enExample)
WO (1) WO1997044668A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002543425A (ja) * 1999-04-30 2002-12-17 ザ ナタン エス． クライン インスティテュート フォー サイキアトリック リサーチ アルツハイマー病の治療のための化合物の同定法
US7090987B1 (en) 1999-04-30 2006-08-15 Nixon Ralph A Methods for the identification of compounds for the treatment of neuronal atrophy-associated dementia
NZ543309A (en) 2003-03-31 2008-12-24 Womens & Childrens Hospital Multiplex screening for lysosomal storage disorders (LSDs)
US7615224B2 (en) * 2004-12-02 2009-11-10 Women's And Children's Hospital Multiplex-bead complex for determination of lysosomal storage disorders
ES2301280A1 (es) * 2005-05-16 2008-06-16 Fina Biotech S.L.U. Metodo para diagnosticar la enfermedad de alzheimer.
WO2007136782A2 (en) * 2006-05-19 2007-11-29 Historx, Inc. Kits and methods for evaluating misfolded proteins
EP2209890A4 (en) * 2006-12-13 2011-11-02 Tgr Biosciences Pty Ltd STIMULATION OF PRODUCTION OF EXTRACELLULAR MEDIA WITH FIBROBLAST CELLS AND / OR STIMULATION OF MIGRATION OF FIBROBLAST CELLS IN A BIOLOGICAL SYSTEM
EP2252325A4 (en) * 2008-03-12 2012-07-11 Amicus Therapeutics Inc TREATMENT OF MORBUS POMPE WITH SPECIFIC PHARMACOLOGICAL CHAPTERONES AND TREATMENT MONITORING WITH SURROGATE MARKERS
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
GB201114909D0 (en) * 2011-08-30 2011-10-12 San Raffaele Centro Fond Biomarkers for lysosomal storage disorders
US8293487B1 (en) * 2012-01-06 2012-10-23 Jiandi Zhang Zestern, a simple, fast, specific and quantifiable improvement of immunodetection process
US9983200B2 (en) 2013-03-14 2018-05-29 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect
US12020820B1 (en) 2017-03-03 2024-06-25 Cerner Innovation, Inc. Predicting sphingolipidoses (fabry's disease) and decision support
US11335461B1 (en) 2017-03-06 2022-05-17 Cerner Innovation, Inc. Predicting glycogen storage diseases (Pompe disease) and decision support
US11923048B1 (en) 2017-10-03 2024-03-05 Cerner Innovation, Inc. Determining mucopolysaccharidoses and decision support tool

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
AU2990692A (en) 1991-12-06 1993-06-10 Commonwealth Scientific And Industrial Research Organisation Diagnostic method for pompe's disease
CA2147887A1 (en) * 1992-10-30 1994-05-11 James W. Dennis Method for measuring glycosyltransferase activity

Also Published As

Publication number Publication date
CA2253875C (en) 2011-02-22
JP2001519894A (ja) 2001-10-23
JP2006061161A (ja) 2006-03-09
CA2253875A1 (en) 1997-11-27
JP2008289501A (ja) 2008-12-04
US6759189B1 (en) 2004-07-06
IL127033A0 (en) 1999-09-22
JP4260152B2 (ja) 2009-04-30
US20040191847A1 (en) 2004-09-30
WO1997044668A1 (en) 1997-11-27
EP1021725B1 (en) 2009-03-18
ATE426169T1 (de) 2009-04-15
EP1021725A1 (en) 2000-07-26
NZ332641A (en) 2000-05-26
CA2731490A1 (en) 1997-11-27
IL127033A (en) 2000-12-06
JP3837711B2 (ja) 2006-10-25
EP1021725A4 (en) 2002-10-30
AUPN991796A0 (en) 1996-06-13

Similar Documents

Publication Publication Date Title
ATE426169T1 (de) Fruher nachweis einer lysosomalen speicher- krankheit
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
ES2172750T3 (es) Microcapsulas sensibles al ph.
DK1169392T3 (da) Vandbaserede polyamidamidsyresammensætninger
BR9914044A (pt) ésteres tetrahidropirido
ATE146360T1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
ES2190803T3 (es) Iminas ciclicas como pesticidas.
WO2003104410A3 (en) ENZYMES
FI973363A0 (fi) Nukleiinihappoja sisältävä koostumus, sen valmistus ja käyttö
ES2158054T3 (es) Extracto proteinico de cucumis melo con actividad antioxidante y procedimiento de preparacion, composicion cosmetica o farmaceutica o composicion alimenticia que contienen dicho extracto.
AU7635396A (en) Treatment and diagnosis of infections due to helicobacter pylori
BR0200571A (pt) Produtos de legumes
WO2000034511A3 (de) Peptid screening test zum nachweis von ass
CA2069611A1 (en) Method to Detect Bone and Other Connective Tissue Disorders in Humans and Animals
WO2002018954A3 (en) Inhibition of cmv infection and dissemination
ATE338142T1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
NO963487L (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
ATE305517T1 (de) Neurotrypsin
FR2850579B1 (fr) Utilisation de mono-ou di-esters d'acide cinnamique ou de l'un de ses derives et de vitamine c, comme donneur de no
BR0115689A (pt) Análise de expressão de inibidor de diferenciação de ácidos nucléicos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
Rokach et al. The effects of culture on the causes of loneliness.
TR199801398T2 (xx) Ast�m� tedavi edici maddeler
WO1999050671A3 (en) Toso as a target for drug screening
NO20004708L (no) Anvendelse av naturlig og/eller syntetisk kininsyre og/eller forlöpere derav som anti-insektsmiddel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition